ATE34572T1 - 1,3-dioxolen-2-on derivate und verfahren zu deren herstellung. - Google Patents

1,3-dioxolen-2-on derivate und verfahren zu deren herstellung.

Info

Publication number
ATE34572T1
ATE34572T1 AT83102898T AT83102898T ATE34572T1 AT E34572 T1 ATE34572 T1 AT E34572T1 AT 83102898 T AT83102898 T AT 83102898T AT 83102898 T AT83102898 T AT 83102898T AT E34572 T1 ATE34572 T1 AT E34572T1
Authority
AT
Austria
Prior art keywords
group
dioxolen
chem
general formula
hydrogen atom
Prior art date
Application number
AT83102898T
Other languages
English (en)
Inventor
Fumio Sakamoto
Shoji Ikeda
Goro Tsukamoto
Isamu Utsumi
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of ATE34572T1 publication Critical patent/ATE34572T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C07D317/40—Vinylene carbonate; Substituted vinylene carbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT83102898T 1980-04-30 1981-04-29 1,3-dioxolen-2-on derivate und verfahren zu deren herstellung. ATE34572T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55058510A JPS6019908B2 (ja) 1980-04-30 1980-04-30 １，３−ジオキソレン−２−オン誘導体
EP83102898A EP0090344B1 (de) 1980-04-30 1981-04-29 1,3-Dioxolen-2-on Derivate und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE34572T1 true ATE34572T1 (de) 1988-06-15

Family

ID=13086410

Family Applications (3)

Application Number Title Priority Date Filing Date
AT87103766T ATE59646T1 (de) 1980-04-30 1981-04-29 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.
AT83102898T ATE34572T1 (de) 1980-04-30 1981-04-29 1,3-dioxolen-2-on derivate und verfahren zu deren herstellung.
AT81103232T ATE10939T1 (de) 1980-04-30 1981-04-29 Verwendung von 1,3-dioxolen-2-on-derivaten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT87103766T ATE59646T1 (de) 1980-04-30 1981-04-29 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT81103232T ATE10939T1 (de) 1980-04-30 1981-04-29 Verwendung von 1,3-dioxolen-2-on-derivaten.

Country Status (7)

Country Link
US (1) US4342693A (de)
EP (3) EP0237084B1 (de)
JP (1) JPS6019908B2 (de)
AT (3) ATE59646T1 (de)
AU (1) AU536686B2 (de)
CA (1) CA1168251A (de)
DE (2) DE3177239D1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76525B (de) * 1981-07-13 1984-08-10 Merck & Co Inc
US4479947A (en) * 1981-07-13 1984-10-30 Merck & Co., Inc. Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group
US4654331A (en) * 1981-07-13 1987-03-31 Merck & Co., Inc. Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group
JPS5869876A (ja) * 1981-07-13 1983-04-26 メルク・エンド・カムパニ−・インコ−ポレ−テツド （５−アルキル−２−オキソ−１，３−ジオキソレン−４−イル）メチルエステル基を用いたカルボン酸医薬の経口吸収増大
JPS5874677A (ja) * 1981-10-30 1983-05-06 Kanebo Ltd 臭素化１，３−ジオキソレン−２−オン類の製造法
JPS5921692A (ja) * 1982-07-29 1984-02-03 Sankyo Co Ltd 経口ペネム化合物及びその製法
US4434173A (en) 1982-08-23 1984-02-28 Pfizer Inc. Bis-esters of 4,5-di(hydroxymethyl)-2-oxo-1,3-dioxole as antibacterial agents
US4555579A (en) * 1983-03-24 1985-11-26 E. R. Squibb & Sons, Inc. Dioxolenylmethyl ester prodrugs of phosphinic acid ace inhibitors
JPS59212488A (ja) * 1983-05-18 1984-12-01 Kyoto Yakuhin Kogyo Kk ジオキソ−ル誘導体
US4536393A (en) * 1983-06-06 1985-08-20 Pfizer Inc. 6-(Aminomethyl)penicillanic acid 1,1-dioxide esters and intermediates therefor
JPS59231082A (ja) * 1983-06-14 1984-12-25 Kanebo Ltd ４−クロロ−４−メチル−５−メチレン−１，３−ジオキソラン−２−オン
US4521533A (en) * 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4777267A (en) * 1986-02-07 1988-10-11 Kanebo Ltd. 1,3-dioxol-2-one derivatives
US4985456A (en) * 1986-08-07 1991-01-15 Mikasa Seiyaku Co., Ltd. 2-anilinophenylacetic acid derivative
ATE186537T1 (de) * 1990-08-20 1999-11-15 Suntory Ltd Antibakterielle penem-ester derivate
ATE242251T1 (de) * 1990-08-20 2003-06-15 Daiichi Suntory Pharma Co Ltd Antibakterielle penem-ester-derivate
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
HU219598B (hu) * 1992-12-17 2001-05-28 Sankyo Co. Ltd. Bifenilvegyületek imidazol- és piridinszármazékai, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
DE19920551A1 (de) * 1999-05-05 2000-11-09 Bayer Ag Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
WO2008059367A1 (en) * 2006-11-14 2008-05-22 Pfizer Products Inc. Penem prodrugs
CN104230878A (zh) * 2014-09-26 2014-12-24 六安科瑞达新型材料有限公司 4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮的制备方法
CN115772150A (zh) * 2022-11-10 2023-03-10 广州理文科技有限公司 一种碳酸乙烯酯氟代衍生物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3020290A (en) * 1959-10-14 1962-02-06 Jefferson Chem Co Inc Preparation of unsaturated compounds

Also Published As

Publication number Publication date
EP0039477B1 (de) 1984-12-27
JPS6019908B2 (ja) 1985-05-18
EP0090344A1 (de) 1983-10-05
EP0237084A3 (en) 1987-09-30
EP0090344B1 (de) 1988-05-25
AU536686B2 (en) 1984-05-17
US4342693A (en) 1982-08-03
ATE59646T1 (de) 1991-01-15
AU6998881A (en) 1981-11-05
EP0237084B1 (de) 1991-01-02
JPS5726684A (en) 1982-02-12
EP0039477A1 (de) 1981-11-11
ATE10939T1 (de) 1985-01-15
CA1168251A (en) 1984-05-29
EP0237084A2 (de) 1987-09-16
DE3167908D1 (de) 1985-02-07
DE3177239D1 (de) 1991-02-07

Similar Documents

Publication Publication Date Title
AU536686B2 (en) 1,3-dioxolen-2-one derivatives
ATE67497T1 (de) Verfahren zur herstellung von thiazolidinedionderivaten.
GB1312536A (en) Hydantoin derivatives
ATE1194T1 (de) Neue 2-alkoxyphenyl-imidazo(4,5-b)pyridine, deren herstellung, deren verwendung zur arzneimittelherstellung und die genannten verbindungen enthaltende arzneimittel.
ATE2428T1 (de) Imidazolguanidine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
DE69607272D1 (de) Herstellung von substituierten Thiazolen
DE3767351D1 (de) Sialosylceramide und verfahren zu deren herstellung.
ATE91682T1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE733T1 (de) 2'-deoxy-5-fluorouridin-derivate, ein verfahren zu deren herstellung und sie enthaltende antitumor-zusammensetzungen.
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
FR2455044A1 (fr) Pyrido-indoles et leur application en therapeutique
DE3887579D1 (de) Mercapto-substituierte Pyridine und Verfahren zu deren Herstellung.
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
ATE57183T1 (de) Herstellung von substituierten gammabutyrolactonen, verwendbar als zwischenprodukte zur herstellung von fungiziden imidazolen und triazolen.
DE69119714D1 (de) Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen
ATE38665T1 (de) Verfahren zur herstellung von 5-perfluoralkyl-5,6-dihydrouracyl-derivaten und verwendbare zwischenprodukte.
FR2383175A1 (fr) Procede de preparation de derives de phenylpyridazinone
DE3866148D1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ATE7137T1 (de) Nitrosoureum-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
ATE28749T1 (de) Verfahren zur herstellung von 3,4-dihydro-alpha- pyronen.
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
ATE92074T1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE52509T1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee